Pregnancy and Childbirth
Conditions
Interventions
MISOCASTOR
MISOPROSTOL
Sponsors
Eze Jeremiah Ugochukwu
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Consenting singleton pregnant women at term Those with unfavourable cervix booked for induction of labour at the study centers.
Exclusion criteria
Exclusion criteria: History of previous uterine scar (C-section or myomectomy) Refusal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure is the median induction delivery interval between term pregnant women that received a combination of vaginal misoprostol 25 µg and oral castor oil 60 ml versus vaginal misoprostol 25 µg alone at the tertiary hospitals in Enugu, Nigeria | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of cervical ripening in tertiary hospitals in Enugu, Incidence of failed induction between the two groups, Compare adverse maternal/neonatal complications between the 2 groups | — |
Countries
Nigeria
Contacts
Public ContactProf. Euzebus .C. Ezugwu
Chairman health research ethis committee
Outcome results
None listed